Feb 4, 2021 5:33pm
Enoxaparin sodium injection is used to treat and prevent deep vein thrombosis as well as heart attacks. (FDA)
Apotex recalled two batches of the anticoagulant enoxaparin after its contract manufacturer discovered it had packaged the drug in syringes with incorrect measurement markings.
Apotex pulled one 100-mg/mL batch of enoxaparin sodium injection and one 120-mg/0.8-mL batch after its CMO, Gland Pharma, received a customer complaint about the syringes.
Certain 120-mg/0.8-mL concentrations of the anticoagulant were packaged in syringes intended for 100-mg/mL concentrations, while some 100 mg/mL concentrations were put into in syringes marked for 150 mg/mL doses.